头孢曲松与头孢唑林敏感性作为肠杆菌科细菌中头孢泊肟敏感性替代标志物的研究
Ceftriaxone Versus Cefazolin Susceptibility as a Surrogate Marker for Cefpodoxime Susceptibility in Enterobacterales.
作者信息
Lambert Kaitlyn V, Demkowicz Ryan, Murray Amanda, Howard Catessa, Slain Douglas
机构信息
Department of Pharmacy Services, WVU Medicine, Morgantown, West Virginia, USA.
Department of Microbiology, WVU Medicine, Morgantown, West Virginia, USA.
出版信息
Open Forum Infect Dis. 2024 Jul 3;11(7):ofae377. doi: 10.1093/ofid/ofae377. eCollection 2024 Jul.
Abstract
The Clinical and Laboratory Standards Institute stated that cefpodoxime susceptibility among Enterobacterales can be inferred from cefazolin, but this may overcall cefpodoxime resistance. We report a categorical agreement rate of 64% for cefazolin and 97% for ceftriaxone with cefpodoxime ( = .0001). Ceftriaxone appears to be a more useful cefpodoxime surrogate.
摘要
临床和实验室标准协会指出，肠杆菌科细菌对头孢泊肟的敏感性可从头孢唑林推断得出，但这可能会高估头孢泊肟耐药性。我们报告头孢唑林与头孢泊肟的分类一致率为64%，头孢曲松与头孢泊肟的分类一致率为97%（P = .0001）。头孢曲松似乎是一种更有用的头孢泊肟替代物。
相似文献
1
Ceftriaxone Versus Cefazolin Susceptibility as a Surrogate Marker for Cefpodoxime Susceptibility in Enterobacterales.头孢曲松与头孢唑林敏感性作为肠杆菌科细菌中头孢泊肟敏感性替代标志物的研究
Open Forum Infect Dis. 2024 Jul 3;11(7):ofae377. doi: 10.1093/ofid/ofae377. eCollection 2024 Jul.
2
Evaluation of cefazolin as a surrogate marker for cefpodoxime susceptibility for urinary tract isolates.评估头孢唑林作为尿路分离株头孢泊肟敏感性替代标志物的作用。
J Med Microbiol. 2015 Oct;64(10):1170-1173. doi: 10.1099/jmm.0.000142. Epub 2015 Jul 23.
3
Prediction of bacterial susceptibility to cefpodoxime by using the ceftriaxone minimum inhibitory concentration result.利用头孢曲松最低抑菌浓度结果预测细菌对头孢泊肟的敏感性
Diagn Microbiol Infect Dis. 1993 Nov-Dec;17(4):313-6. doi: 10.1016/0732-8893(93)90041-5.
4
Susceptibility of Neisseria gonorrhoeae to cefpodoxime: determination of MICs and disk diffusion zone diameters.淋病奈瑟菌对头孢泊肟的敏感性：最低抑菌浓度（MICs）及纸片扩散法抑菌圈直径的测定
Antimicrob Agents Chemother. 1991 Mar;35(3):497-9. doi: 10.1128/AAC.35.3.497.
5
The sensitivity of 173 Sydney isolates of Neisseria gonorrhoeae to cefpodoxime and other antibiotics used to treat gonorrhea.173株悉尼淋病奈瑟菌分离株对头孢泊肟及其他用于治疗淋病的抗生素的敏感性。
Pathology. 1995 Jan;27(1):64-6. doi: 10.1080/00313029500169492.
6
Linezolid versus ceftriaxone/cefpodoxime in patients hospitalized for the treatment of Streptococcus pneumoniae pneumonia.利奈唑胺与头孢曲松/头孢泊肟用于住院治疗肺炎链球菌肺炎患者的比较。
Scand J Infect Dis. 2002;34(10):720-8. doi: 10.1080/0036554021000026933.
7
Correlation of cefpodoxime susceptibility with cephalothin and cefuroxime for urinary tract isolates.头孢泊肟药敏与头孢噻肟和头孢呋辛酯对尿路感染分离株的相关性。
J Med Microbiol. 2014 Feb;63(Pt 2):218-221. doi: 10.1099/jmm.0.063040-0. Epub 2013 Nov 8.
8
Leveraging stewardship to promote ceftriaxone use in severe infections with low- and no-risk AmpC Enterobacterales.利用管理策略促进头孢曲松在低风险和无风险 AmpC 肠杆菌科严重感染中的应用。
Antimicrob Agents Chemother. 2023 Nov 15;67(11):e0082623. doi: 10.1128/aac.00826-23. Epub 2023 Oct 26.
9
Surrogate testing of oral third-generation cephalosporin susceptibility to common uropathogens.常见尿路病原体的第三代口服头孢菌素药敏性的替代检测。
Diagn Microbiol Infect Dis. 2021 Apr;99(4):115299. doi: 10.1016/j.diagmicrobio.2020.115299. Epub 2021 Jan 15.
10
Continued in vitro cefazolin susceptibility in methicillin-susceptible Staphylococcus aureus.耐甲氧西林金黄色葡萄球菌的体外头孢唑林持续敏感。
Ann Clin Microbiol Antimicrob. 2018 Feb 20;17(1):5. doi: 10.1186/s12941-018-0257-x.
引用本文的文献
1
Navigating the Muddled Middle: A Case-Based Exploration of Oral β-Lactams for Systemic Gram-Negative Infections.探索复杂的中间地带：基于病例探讨口服β-内酰胺类药物治疗全身性革兰氏阴性菌感染
Open Forum Infect Dis. 2025 Sep 3;12(9):ofaf435. doi: 10.1093/ofid/ofaf435. eCollection 2025 Sep.
2
How accurate is ceftriaxone at predicting susceptibility of enterobacterales isolates to oral higher-generation cephalosporins?头孢曲松在预测肠杆菌科分离株对口服高级别头孢菌素的敏感性方面有多准确？
Antimicrob Agents Chemother. 2025 Feb 13;69(2):e0138724. doi: 10.1128/aac.01387-24. Epub 2024 Dec 31.
本文引用的文献
1
Comparative-Effectiveness of Oral Beta-Lactams and Fluoroquinolones for Stepdown Therapy in Patients with Enterobacterales Bloodstream Infections: A Retrospective Cohort Study.口服β-内酰胺类药物与氟喹诺酮类药物在下尿路感染患者降阶梯治疗中的比较效果：一项回顾性队列研究。
Int J Med Sci. 2023 Feb 13;20(4):437-443. doi: 10.7150/ijms.80621. eCollection 2023.
2
Antimicrobial Activity of Tebipenem and Comparators against Enterobacterales from diverse Outpatient Centers and Nursing Homes in the United States.替比培南及对照药物对美国不同门诊中心和疗养院肠杆菌科的抗菌活性。
Int J Antimicrob Agents. 2023 Mar;61(3):106733. doi: 10.1016/j.ijantimicag.2023.106733. Epub 2023 Jan 20.
3
Optimizing the Management of Uncomplicated Gram-Negative Bloodstream Infections: Consensus Guidance Using a Modified Delphi Process.优化非复杂性革兰阴性菌血流感染的管理：采用改良德尔菲法的共识指南
Open Forum Infect Dis. 2021 Oct 11;8(10):ofab434. doi: 10.1093/ofid/ofab434. eCollection 2021 Oct.
4
Can the Ceftriaxone Breakpoints Be Increased Without Compromising Patient Outcomes?头孢曲松的药敏断点提高会影响患者预后吗？
Open Forum Infect Dis. 2018 Jun 8;5(6):ofy139. doi: 10.1093/ofid/ofy139. eCollection 2018 Jun.
5
Evaluation of cefazolin as a surrogate marker for cefpodoxime susceptibility for urinary tract isolates.评估头孢唑林作为尿路分离株头孢泊肟敏感性替代标志物的作用。
J Med Microbiol. 2015 Oct;64(10):1170-1173. doi: 10.1099/jmm.0.000142. Epub 2015 Jul 23.
6
Correlation of cefpodoxime susceptibility with cephalothin and cefuroxime for urinary tract isolates.头孢泊肟药敏与头孢噻肟和头孢呋辛酯对尿路感染分离株的相关性。
J Med Microbiol. 2014 Feb;63(Pt 2):218-221. doi: 10.1099/jmm.0.063040-0. Epub 2013 Nov 8.
7
Cefazolin and enterobacteriaceae: rationale for revised susceptibility testing breakpoints.头孢唑林和肠杆菌科：修订药敏试验折点的原理。
Clin Infect Dis. 2011 Apr 1;52(7):917-24. doi: 10.1093/cid/cir031.
8
Problems related to determination of MICs of oximino-type expanded-spectrum cephems for Proteus vulgaris.与测定氧亚氨基型广谱头孢菌素对普通变形杆菌的最低抑菌浓度相关的问题。
J Clin Microbiol. 2000 Feb;38(2):677-81. doi: 10.1128/JCM.38.2.677-681.2000.
9
Prediction of bacterial susceptibility to cefpodoxime by using the ceftriaxone minimum inhibitory concentration result.利用头孢曲松最低抑菌浓度结果预测细菌对头孢泊肟的敏感性
Diagn Microbiol Infect Dis. 1993 Nov-Dec;17(4):313-6. doi: 10.1016/0732-8893(93)90041-5.
Zotero 插件